2420 J. Agric. Food Chem., Vol. 46, No. 6, 1998
Abad et al.
6-[[1-(4-(Methylthio)phenyloxy)carbonyl]amino]hexanoic Acid
(MPNH): 1H NMR (acetone-d6) δ 1.35-1.70 (m, 6 H, CH2-
CH2-CH2), 2.30 (t, 2 H, CH2-COOH), 2.46 (s, 3 H, S-CH3),
3.19 (q, 2 H, CH2-NH), 7.08 (m, 2 H, aromatic), 7.25 (m, 2 H,
aromatic); 13C NMR (acetone-d6) δ 16.70, 25.76, 27.40, 30.71,
34.53, 42.00, 123.61, 128.80, 135.77, 150.76, 155.73, 175.14.
3-[[1-(Phenyloxy)carbonyl]amino]propanoic Acid (PNP): 1H
NMR (acetone-d6) δ 2.61 (t, 2 H, CH2-COOH), 3.46 (q, 2 H,
CH2-NH), 7.09-7.37 (m, 5 H, aromatic); 13C NMR (acetone-
d6) δ 34.69, 37.69, 122.46, 125.62, 129.86, 152.45, 155.21,
173.10.
protein, and the corresponding conjugate. By assuming that
the molar absorptivity of haptens was the same for the free
and conjugated forms, apparent molar ratios were estimated
as 27, 16, and 18 for haptens MXNP, MXNB, and MXNH,
respectively.
P r ep a r a tion of Coa tin g Con ju ga tes. All of the haptens
were covalently attached to OVA using the mixed-anhydride
method (Rajkowski et al., 1977). Eighteen micromoles of the
hapten was allowed to react at room temperature for 1 h with
stoichiometric amounts of tri-n-butylamine and isobutyl chlo-
roformate in 200 µL of DMF. One hundred microliters of the
resulting activated hapten was added to 30 mg of OVA in 2
mL of 50 mM carbonate buffer, pH 9.6. The coupling reaction
was incubated at room temperature for 2-3 h with stirring,
and the conjugates obtained were purified as described for the
immunogens. The extent of coupling of each hapten to OVA
was determined by UV spectrophotometry. By assuming
additive absorbance values, hapten to protein molar ratios
were evaluated as 5, 5, 6, 9, 8, 8, 2, 4, 4, 2, 2, 4, 9, 6, 2, 2, 4,
and 6 for haptens MXNP, MXNB, MXNH, DPNP, DPNB,
DPNH, MCNP, MCNB, MCNH, MPNP, MPNB, MPNH, PNP,
PNB, PNH, MXOA, MXOB, and MXOH, respectively.
P r ep a r a tion of En zym e Con ju ga tes. The mixed-anhy-
dride method was also used for covalent coupling of haptens
to HRP. Typically, 2.9 µL of tributylamine and 1.6 µL of
isobutyl chloroformate were added to 13.3 µmol of the hapten
in 200 µL of DMF. The mixture was stirred for 1 h at room
temperature. After the addition of 1.8 mL of DMF, 100 µL of
this diluted solution of activated hapten was incubated for 2
h at room temperature with 1 mL of a 2.2 mg/mL solution of
HRP in 50 mM carbonate buffer, pH 9.6. HRP-hapten
conjugates were purified as described for the immunogens.
HRP conjugate concentrations and molar ratios were estimated
spectrophotometrically. With the same assumptions as before,
the estimated molar ratios were 1.7, 3.0, 4.6, 11.5, 11.3, 11.5,
2.3, 1.4, 3.2, 1.7, 3.4, and 1.5 for haptens MXNP, MXNB,
MXNH, DPNP, DPNB, DPNH, MCNP, MCNB, MCNH, MXOA,
MXOB, and MXOH, respectively.
P r od u ction of Mon oclon a l An tibod ies to Meth ioca r b.
Immunization. BALB/c female mice (8-10 weeks old) were
immunized with BSA-MXNP, -MXNB, and -MXNH conju-
gates. First dose consisted of 30 µg of conjugate intraperito-
neally injected as an emulsion of PBS and complete Freund’s
adjuvant. Two subsequent injections were given at 3-week
intervals emulsified in incomplete Freund’s adjuvant. One
week after the last injection, mice were tail-bled and sera
tested for anti-hapten antibody titer by indirect ELISA and
for analyte recognition properties by competitive indirect
ELISA. After a resting period of at least 3 weeks from the
last injection in adjuvant, mice selected to be spleen donors
for hybridoma production received a final soluble intraperi-
toneal injection of 100 µg of conjugate in PBS, 4 days prior to
cell fusion.
4-[[1-(Phenyloxy)carbonyl]amino]butanoic Acid (PNB): 1H
NMR (acetone-d6) δ 1.88 (m, 2 H, CH2-CH2-CH2), 2.40 (t, 2
H, CH2-COOH), 3.26 (q, 2 H, CH2-NH), 7.09-7.37 (m, 5 H,
aromatic); 13C NMR (acetone-d6) δ 25.80, 31.34, 41.04, 122.50,
125.54, 129.85, 152.52, 155.37, 174.42.
6-[[1-(Phenyloxy)carbonyl]amino]hexanoic Acid (PNH): 1H
NMR (acetone-d6) δ 1.36-1.68 (m, 6 H, CH2-CH2-CH2), 2.30
(t, 2 H, CH2-COOH), 3.20 (q, 2 H, CH2-NH), 7.09-7.37 (m,
5 H, aromatic); 13C NMR (acetone-d6) δ 25.42, 26.91, 30.20,
34.01, 41.34, 41.48, 122.49, 125.48, 129.83, 152.57, 155.30,
174.62.
6-[1-(4-(Methylthio)-3,5-xylyloxy)]hexanoic Acid (MXOH, Fig-
ure 2). To 50 mL of dry acetone were added stoichiometric
amounts (20 mmol) of 4-(methylthio)-3,5-xylenol, potassium
carbonate, and ethyl 6-bromohexanoate. After reflux for 12
h, the mixture was filtered and the solvent was removed under
reduced pressure. The residue was dissolved in 50 mL of ethyl
acetate, washed with water (2 × 50 mL), 1 M NaOH (2 × 50
mL), and 4 M NaCl (2 × 50 mL), and finally dried over Na2SO4.
GC analysis confirmed that 43% of the crude product was ethyl
6-[(1-(4-(methylthio)-3,5-xylyloxy)]hexanoate. After evapora-
tion of the solvent, 50 mL of 1 M NaOH was added to the
residue (4.91 g), and the solution was stirred while heated
under reflux for 1.5 h. The solution was then acidified with
concentrated hydrochloric acid, extracted with ethyl acetate,
and dried over Na2SO4. The oily product obtained after solvent
evaporation (1.55 g, 27%) was crystallized from hexane to
obtain 640 mg of the pure hapten: 1H NMR (acetone-d6) δ
1.40-1.80 (m, 6 H, CH2-CH2-CH2), 2.15 (s, 3 H, S-CH3), 2.33
(t, 2 H, CH2-COOH), 2.49 (s, 6 H, 2 CH3), 3.40 (t, 2 H, O-CH2),
6.72 (s, 2 H, aromatic); 13C NMR (acetone-d6) δ 18.60, 21.97,
25.34, 26.29, 34.06, 68.12, 114.89, 126.59, 144.82, 159.76,
174.61.
From appropriate spacers, the following compounds were
synthesized also by O-alkylation of 4-(methylthio)-3,5-xylenol.
2-[1-(4-(Methylthio)-3,5-xylyloxy)]acetic Acid (MXOA): 1H
NMR (acetone-d6) δ 2.16 (s, 3 H, S-CH3), 2.50 (s, 6 H, 2 CH3),
4.70 (s, 2 H, CH2-COOH), 6.75 (s, 2 H, aromatic); 13C NMR
(acetone-d6) δ 18.51, 21.98, 65.04, 114.93, 127.62, 144.94,
158.66, 170.07.
4-[1-(4-(Methylthio)-3,5-xylyloxy)]butanoic Acid (MXOB): 1H
NMR (acetone-d6) δ 2.04 (m, 2 H, CH2-CH2-CH2), 2.15 (s, 3
H, S-CH3), 2.49 (t, 2 H, CH2-COOH), 2.49 (s, 6 H, 2 CH3),
4.02 (t, 2 H, O-CH2), 6.74 (s, 2 H, aromatic); 13C NMR (acetone-
d6) δ 18.58, 21.97, 25.34, 67.30, 114.90, 126.79, 144.86, 159.58,
174.32.
Cell Fusion. P3-X63/Ag 8.653 murine myeloma cells (ATCC,
Rockville, MD) were cultured in high-glucose DMEM supple-
mented with 2 mM L-glutamine, 1 mM nonessential amino
acids, 25 µg/mL gentamicin, and 15% fetal bovine serum
(referred to as s-DMEM). Cell fusion procedures were carried
out essentially as described by Nowinski et al. (1979). Mouse
spleen lymphocytes were fused with myeloma cells at a 5:1
ratio using PEG 1500 as the fusing agent. The fused cells were
distributed in 96-well culture plates at an approximate density
of (4-5) × 105 cells/well in 100 µL of s-DMEM. Twenty-four
hours after plating, 100 µL of HAT selection medium (s-DMEM
supplemented with 100 µM hypoxanthine, 0.4 µM aminopter-
ine, and 16 µM thymidine) was added to each well. Half the
medium of the wells was replaced by fresh HAT medium on
day 4 postfusion and by HT medium (HAT medium without
aminopterine) on day 8 postfusion.
P r ep a r a t ion of Im m u n izin g Con ju ga t es. Haptens
MXNP, MXNB, and MXNH were covalently attached to BSA
using the modified active ester method (Langone and Van
Vunakis, 1982). Twenty-five micromoles of the hapten was
incubated overnight at room temperature with stoichiometric
amounts of N-hydroxysuccinimide and dicyclohexylcarbodi-
imide in 0.5 mL of DMF. After centrifuging, 400 µL of the
clear supernatant containing the active ester was slowly added
to 2 mL of a 15 mg/mL BSA solution in 50 mM carbonate
buffer, pH 9.6. The mixture was allowed to react at room
temperature for 4 h with stirring, and finally the conjugate
was purified by gel filtration on Sephadex G-50 using 100 mM
sodium phosphate buffer, pH 7.4, as eluant. Conjugate
formation was confirmed spectrophotometrically. UV-vis
spectra showed qualitative differences between the carrier
protein and conjugates in the region of maximum absorbance
of haptens. The hapten to protein molar ratio of conjugates
was then estimated from the spectral data of the hapten, the
Hybridoma Selection and Cloning. Eight to 11 days after
cell fusion, culture supernatants were screened for the pres-
ence of antibodies that recognized methiocarb. The screening
consisted of the simultaneous performance of a noncompetitive
and a competitive indirect ELISA, to test the ability of
antibodies to bind the OVA conjugate of the immunizing